KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.612 $13.48 Friday, 26th Apr 2024 ACOR stock ended at $0.661. During the day the stock fluctuated 0% from a day low at $0.661 to a day high of $0.661.
90 days $0.612 $17.15
52 weeks $0.449 $18.21

Historical Acorda Therapeutics prices

Date Open High Low Close Volume
Apr 12, 2016 $27.68 $27.68 $27.68 $27.68 538 546
Apr 11, 2016 $27.41 $27.41 $27.41 $27.41 593 126
Apr 08, 2016 $27.66 $27.66 $27.66 $27.66 1 023 638
Apr 07, 2016 $27.44 $27.44 $27.44 $27.44 956 405
Apr 06, 2016 $27.98 $27.98 $27.98 $27.98 1 506 324
Apr 05, 2016 $26.41 $26.41 $26.41 $26.41 1 022 592
Apr 04, 2016 $26.05 $26.05 $26.05 $26.05 717 726
Apr 01, 2016 $27.09 $27.09 $27.09 $27.09 953 526
Mar 31, 2016 $26.45 $26.45 $26.45 $26.45 996 370
Mar 30, 2016 $26.43 $26.43 $26.43 $26.43 720 932
Mar 29, 2016 $26.11 $26.11 $26.11 $26.11 1 124 200
Mar 28, 2016 $25.38 $25.38 $25.38 $25.38 800 800
Mar 24, 2016 $25.79 $25.79 $25.79 $25.79 1 011 000
Mar 23, 2016 $25.71 $25.71 $25.71 $25.71 682 000
Mar 22, 2016 $27.33 $27.33 $27.33 $27.33 1 519 100
Mar 21, 2016 $25.93 $25.93 $25.93 $25.93 940 000
Mar 18, 2016 $26.43 $26.43 $26.43 $26.43 1 881 600
Mar 17, 2016 $25.61 $25.61 $25.61 $25.61 1 471 300
Mar 16, 2016 $26.79 $26.79 $26.79 $26.79 2 483 900
Mar 15, 2016 $28.14 $28.14 $28.14 $28.14 2 180 700
Mar 14, 2016 $29.45 $29.45 $29.45 $29.45 2 879 900
Mar 11, 2016 $32.00 $32.00 $32.00 $32.00 2 678 300
Mar 10, 2016 $34.71 $34.71 $34.71 $34.71 339 800
Mar 09, 2016 $36.03 $36.03 $36.03 $36.03 549 100
Mar 08, 2016 $35.34 $35.34 $35.34 $35.34 395 500
Click to get the best stock tips daily for free!

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT